Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Aurélie De Rus Jacquet × Clear Filters

2 results found

Shifting perspectives in Parkinson's disease: can peripheral immune cells induce neurodegeneration without vascular transmigration?

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the world and affects over 100,000 Canadians. It causes movement difficulties and other symptoms that worsen over time. Although treatments can relieve symptoms, none can stop or slow the progression of the disease. Scientists have long focused on brain cells as the main source of damage in PD, but new evidence suggests that immune cells circulating in the blood may also play a crucial role.

Project ongoing See Project & Researchers
Grant type
Team grants
Area of Research
Neurodegeneration
Competition
Accelerator Grants: Neurodegeneration x Immunology
Province
Québec
Start Date
2026

Developing vascularized brain-on-chip technologies: the next frontier in neuroscientific research

Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease and the fastest growing neurodegenerative disorder worldwide.

Project ongoing See Project & Researchers
Grant type
Capacity building grants
Area of Research
Neurotechnology
Competition
Future Leaders in Canadian Brain Research
Province
Québec
Start Date
2024